FDA Approves Updated Labeling for First Pan-Genotypic, Once-Daily STR for Treatment of HCV (8/14/17)

https://www.drugs.com/newdrugs/fda-approves-expanded-labeling-epclusa-sofosbuvir-velpatasvir-chronic-hepatitis-c-patients-co-4575.html